Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review | Zendy

Giovanni A. Fava | Zendy; Giada Benasi | Zendy; Marcella Lucente | Zendy; Emanuela Offidani | Zendy; Fiammetta Cosci | Zendy; Jenny Guidi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review

Author(s) -

Giovanni A. Fava,

Giada Benasi,

Marcella Lucente,

Emanuela Offidani,

Fiammetta Cosci,

Jenny Guidi

Publication year - 2018

Publication title -

psychotherapy and psychosomatics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.531

H-Index - 98

eISSN - 1423-0348

pISSN - 0033-3190

DOI - 10.1159/000491524

Subject(s) - discontinuation , venlafaxine , milnacipran , reuptake inhibitor , medicine , cochrane library , serotonin reuptake inhibitor , duloxetine , randomized controlled trial , psychiatry , antidepressant , anxiety , alternative medicine , pathology

Serotonin-noradrenaline reuptake inhibitors (SNRI) are widely used in medical practice. Their discontinuation has been associated with a wide range of symptoms. The aim of this paper is to identify the occurrence, frequency, and features of withdrawal symptoms after SNRI discontinuation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research